Your Search Results

TAVI procedural complications - Part 9: coronary occlusion, difficult aortic valve crossing and more

21 May 2026 – From EuroPCR 2026

Explore the management of complex TAVI procedural complications, including coronary occlusion and difficult valve crossing. This session presents innovative bailout techniques, diagnostic challenges, and case-based discussions highlighting acute coronary syndrome post-TAVI and nuanced approaches to valve-in-valve interventions.

Mitral valve-in-valve, valve-in-ring, valve-in-mac: the good, the bad and the ugly

20 May 2026 – From EuroPCR 2026

This session delves into the complexities of mitral valve interventions, focusing on valve-in-valve, valve-in-ring, and valve-in-mitral annular calcification (MAC) procedures. It addresses troubleshooting in high-risk valve-in-MAC cases, urgent transcatheter mitral valve implantation supported by microaxial flow pumps, challenges in delivering balloon expandable valves transeptally, and innovative...

Mitral interventions: procedural risk assessment and interventions

21 May 2026 – From EuroPCR 2026

Focused on mitral valve interventions, this session covers procedural risk assessment and outcomes following transcatheter edge-to-edge repair (TEER). Topics include predictive risk scores, technical complexity, pulmonary artery pressure indices, right ventricle-pulmonary artery coupling, and novel imaging predictors influencing procedural success and patient prognosis.

Complex distal LM PCI challenges (trifurcations and more)

20 May 2026 – From EuroPCR 2026

Focusing on the intricacies of complex distal left main PCI, this session covers challenging trifurcation lesions and emergency interventions. It includes IVUS-guided approaches for trifurcation PCI, management of calcified left main trifurcations, and multidisciplinary team rescue strategies for unstable left main bifurcation disease.

Inflammation and cardiovascular risk

21 May 2026 – From EuroPCR 2026

Exploring the interplay between inflammation and cardiovascular risk, this session reviews contemporary research on residual risk post-PCI, inflammatory markers in coronary artery disease especially in type 2 diabetes and ACS, and prognostic tools including lipoprotein(a) and systemic inflammation indices.

Images that speak for themselves

20 May 2026 – From EuroPCR 2026

This visually-driven session presents compelling clinical cases where imaging played a decisive role. Cases include unexpected challenges following transcatheter tricuspid valve replacement, severe hypertension in a young athlete, atypical coronary artery anatomy, critical moments of cardiac arrest, and unique coronary artery findings resembling a spider web.

Modern risk prediction in TAVI

21 May 2026 – From EuroPCR 2026

This session examines modern risk prediction models in transcatheter aortic valve implantation (TAVI). It presents novel scoring systems, the prognostic significance of cardiac damage extent and progression, and the impact of multivalvular disease, enhancing patient stratification and outcome prediction.

Imaging to the rescue in LAA closure

20 May 2026 – From EuroPCR 2026

This session highlights the pivotal role of advanced imaging modalities in left atrial appendage (LAA) closure. Topics include novel risk assessment workflows for air embolism, evaluation protocols using cardiac CT and 3D TEE, reproducibility of anatomical classifications, and long-term follow-up outcomes with various imaging techniques.

POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?

02 Sep 2024

Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.

Author

Luis Ortega-Paz

Comparison of puncture success rate between distal radial access and transradial access in patients with ST-elevation myocardial infarction (DRAMI)

07 Nov 2024

Aaysha Cader provides her take on the DRAMI trial presented by Jun-Won Lee at TCT 2024 in Washington.

Author

Aaysha Cader

Comparison of puncture success rate between distal radial access and transradial access in patients with STEMI (DRAMI)

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Author

Alessandro Sticchi

Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes across key global studies presented at TCT 2025

29 Oct 2025

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.